Shaun Carter
Geen lopende functies
Profiel
Shaun Carter worked as a Group Development & Strategy Director at Intersect ENT, Inc. and as a Director-Group Development & Strategy at Carillion Plc.
He holds an MBA from Warwick Business School.
Eerdere bekende functies van Shaun Carter
| Bedrijven | Functie | Einde |
|---|---|---|
| CARILLION PLC | Corporate Officer/Principal | 31-12-2017 |
| INTERSECT ENT, INC. | Corporate Officer/Principal | - |
Opleiding van Shaun Carter
| Warwick Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CARILLION PLC | Industrial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
